reference/33617761

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33617761

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	7540
issn	0027-8424 1091-6490
issueIdentifier	18
pageRange	7535-7540
publicationName	Proceedings of the National Academy of Sciences of the United States of America
startingPage	7535
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1da4302817d591c8c388e14ee7f8338f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c675910307d8a813526a9d3773264e44
bibliographicCitation	Katayama R, Khan TM, Benes C, Lifshits E, Ebi H, Rivera VM, Shakespeare WC, Iafrate AJ, Engelman JA, Shaw AT. Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proc Natl Acad Sci U S A. 2011 May 03;108(18):7535–40. PMID: 21502504; PMCID: PMC3088626.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd453c3236b7907cd7b6cc140ff42c24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3610899750b7dd32eff62d0f54d0f3e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_990d93baa910ea000185456b8d8b56a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_721f89fa2a308f119945a5a1c8c47e7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ee84a2db02d192e64e3bca15441f32e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0f9d2379f959f2dfd9b70a55d1c2b32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d9e82a73b505af9c10aebd9a41d358c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef6dbe0e0601c591a99adb6fb3d4936b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e49790477009dcf65772ab641660bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_516e2e92958895fd6a2a3fb492743385
date	2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3088626 https://doi.org/10.1073/pnas.1019559108 https://pubmed.ncbi.nlm.nih.gov/21502504
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6653 https://portal.issn.org/resource/ISSN/0027-8424 https://portal.issn.org/resource/ISSN/1091-6490
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
discusses	http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0027090 http://id.nlm.nih.gov/mesh/M000632371 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M0513130 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0015421 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0506216 http://id.nlm.nih.gov/mesh/M0406100 http://id.nlm.nih.gov/mesh/M0018226
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D011720Q000494 http://id.nlm.nih.gov/mesh/D015514Q000235 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D000970Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D011725Q000627 http://id.nlm.nih.gov/mesh/D000077547 http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D015514Q000037 http://id.nlm.nih.gov/mesh/D014162 http://id.nlm.nih.gov/mesh/D034741Q000235 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D017931Q000235 http://id.nlm.nih.gov/mesh/D011743Q000494 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D009943Q000494 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D017404 http://id.nlm.nih.gov/mesh/D011720Q000627 http://id.nlm.nih.gov/mesh/D015151
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134694678 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9812d46bb63b7ca1d737789c0e1430b0 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131954773 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131750287 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ec03999a28cdaaeb3c7910122bdd5b6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b23065537a07b03ba7e2ca1197841172 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24870925 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57390074 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16038120 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133688938 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6525311 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6505803 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133538837 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6440175 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139592711 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458730

Incoming Links

Predicate	Subject
citesAsDataSource	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223366074_AID1345502_PMID21502504_VALUE21 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223366074_AID1345550_PMID21502504_VALUE3
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788495 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID238 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229599 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160644611 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135727576 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223366074

Total number of triples: 107.